Actinium Pharmaceuticals
ATNM
#9825
Rank
C$64.85 M
Marketcap
C$2.08
Share price
4.14%
Change (1 day)
16.99%
Change (1 year)

Earnings for Actinium Pharmaceuticals (ATNM)

Earnings in 2025 (TTM): -C$61.97 Million

According to Actinium Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -C$58 Million, an increase over its 2023 earnings that were of -C$71.49 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Actinium Pharmaceuticals from 2007 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$61.97 Million6.85%
2024 -C$58 Million-18.87%
2023 -C$71.49 Million52.24%
2022 -C$46.96 Million36.61%
2021 -C$34.38 Million11.48%
2020 -C$30.84 Million1.46%
2019 -C$30.39 Million-7.37%
2018 -C$32.81 Million-11.46%
2017 -C$37.06 Million10.67%
2016 -C$33.49 Million15.7%
2015 -C$28.94 Million-14.86%
2014 -C$34 Million129.19%
2013 -C$14.84 Million-8.55%
2012 -C$16.22 Million
2010 C$0.01 M-152.15%
2009 -C$0.03 Million-39.8%
2008 -C$0.04 Million120.29%
2007 -C$0.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Genocea Biosciences
GNCA
-C$51.21 Million-15.95%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$0.93 B-1,635.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
C$6.85 M-111.26%๐Ÿ‡บ๐Ÿ‡ธ USA